Home LongBio Pharma Files for Hong Kong IPO Under Chapter 18A to Advance Allergy and Autoimmune Biologics Pipeline

LongBio Pharma Files for Hong Kong IPO Under Chapter 18A to Advance Allergy and Autoimmune Biologics Pipeline

CST Updated May 22, 2026 10:02